Value the allocation of innovative pharmaceutical targets, with long-term capital continuing to enter the market.

In the recent adjustment market, long-term funds continue to increase their positions in the innovative pharmaceutical sector. At the same time, the launch of innovative pharmaceutical theme funds will bring in additional funds. In the eyes of industry professionals, the long-term allocation value of the innovative pharmaceutical sector is evident, but due to the strong rise in the previous period, it is necessary to distinguish between true and false in the future market, and investment should focus on high-quality companies.